Farouc A. Jaffer

A novel near-infrared fluorescence sensor for detection of thrombin activation in blood.

Age and sex distribution of subclinical aortic atherosclerosis: a magnetic resonance imaging examination of the Framingham Heart Study.

In vivo imaging of thrombin activity in experimental thrombi with thrombin-sensitive near-infrared molecular probe.

Novel factor XIII probes for blood coagulation imaging.

Seeing within: molecular imaging of the cardiovascular system.

Molecular imaging of factor XIIIa activity in thrombosis using a novel, near-infrared fluorescent contrast agent that covalently links to thrombi.

Near-infrared fluorescent imaging of cerebral thrombi and blood-brain barrier disruption in a mouse model of cerebral venous sinus thrombosis.

Molecular imaging in the clinical arena.

A branched fluorescent peptide probe for imaging of activated platelets.

Images in cardiovascular medicine. Culprit lesion atherothrombectomy during acute myocardial infarction: extraction of an acute coronary plaque rupture.

Factor XIII deficiency causes cardiac rupture, impairs wound healing, and aggravates cardiac remodeling in mice with myocardial infarction.

Molecular and cellular imaging of atherosclerosis: emerging applications.

Detection of macrophage activity in atherosclerosis in vivo using multichannel, high-resolution laser scanning fluorescence microscopy.

Monocyte accumulation in mouse atherogenesis is progressive and proportional to extent of disease.

Cellular imaging of inflammation in atherosclerosis using magnetofluorescent nanomaterials.

Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis.

Molecular imaging of myocardial infarction.

Case records of the Massachusetts General Hospital. Case 34-2006. A 72-year-old woman with nausea followed by hypotension and respiratory failure.

A macrophage-targeted theranostic nanoparticle for biomedical applications.

Multimodality molecular imaging identifies proteolytic and osteogenic activities in early aortic valve disease.

Assessment by cardiovascular magnetic resonance, electron beam computed tomography, and carotid ultrasonography of the distribution of subclinical atherosclerosis across Framingham risk strata.

Optical visualization of cathepsin K activity in atherosclerosis with a novel, protease-activatable fluorescence sensor.

Molecular imaging of cardiovascular disease.

Osteogenesis associates with inflammation in early-stage atherosclerosis evaluated by molecular imaging in vivo.

Transglutaminase activity in acute infarcts predicts healing outcome and left ventricular remodelling: implications for FXIII therapy and antithrombin use in myocardial infarction.

Advances in molecular imaging of atherosclerotic vascular disease.

Real-time catheter molecular sensing of inflammation in proteolytically active atherosclerosis.

A new approach to reconstruction of central aortic blood pressure using 'adaptive' transfer function.

Arterial and aortic valve calcification abolished by elastolytic cathepsin S deficiency in chronic renal disease.

The year in molecular imaging.

Optical and multimodality molecular imaging: insights into atherosclerosis.

Multimodal nanoagents for the detection of intravascular thrombi.

Assessing niacin as an atherosclerosis therapeutic agent valuable insights provided by high-resolution vascular magnetic resonance imaging.

Optical molecular imaging in atherosclerosis.

Clinical outcomes and cost-effectiveness of coronary computed tomography angiography in the evaluation of patients with chest pain.

Intravascular near-infrared fluorescence molecular imaging of atherosclerosis: toward coronary arterial visualization of biologically high-risk plaques.

Near-infrared fluorescence catheter system for two-dimensional intravascular imaging in vivo.

Pioglitazone suppresses inflammation in vivo in murine carotid atherosclerosis: novel detection by dual-target fluorescence molecular imaging.

A light-activated theranostic nanoagent for targeted macrophage ablation in inflammatory atherosclerosis.

Case records of the Massachusetts General Hospital. Case 28-2010. A 32-year-old woman, 3 weeks post partum, with substernal chest pain.

The year in molecular imaging.

Residual thrombogenic substrate after rupture of a lipid-rich plaque: possible mechanism of acute stent thrombosis?

Intravital fluorescence microscopic molecular imaging of atherosclerosis.

Projected cost-effectiveness of smoking cessation interventions in patients hospitalized with myocardial infarction.

F-FDG PET Imaging of Atherosclerosis-A New Approach to Detect Inflamed, High-Risk Coronary Plaques?

Intravascular laser speckle imaging catheter for the mechanical evaluation of the arterial wall.

Indocyanine green enables near-infrared fluorescence imaging of lipid-rich, inflamed atherosclerotic plaques.

Two-dimensional intravascular near-infrared fluorescence molecular imaging of inflammation in atherosclerosis and stent-induced vascular injury.

Intravascular optical imaging technology for investigating the coronary artery.

Rationale and design of the DeFACTO (Determination of Fractional Flow Reserve by Anatomic Computed Tomographic AngiOgraphy) study.

The role of nanomedicine in the imaging and therapy of thrombosis.

Intra-arterial catheter for simultaneous microstructural and molecular imaging in vivo.

Progress on multimodal molecular / anatomical intravascular imaging of coronary vessels combining near infrared fluorescence and ultrasound.